Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. 1998

J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
Division of Cardiology, University of Utah, LDS Hospital, Salt Lake City 84143, USA.

OBJECTIVE We tested for an association between the angiotensin-converting enzyme (ACE) DD polymorphic genotype and myocardial infarction (MI) in a sample group composed exclusively of women. BACKGROUND The human ACE gene occurs with either an insertion (I allele) or a deletion (D allele) of a 287-base pair (bp) Alu element. Part of the variance in serum ACE levels may be accounted for by this polymorphism. Also, the DD genotype has been associated with an increased risk of MI in predominantly male populations. However, the risk in women is poorly defined. METHODS Genomic DNA was extracted from buffy coat blood using a phenol/chloroform method. Angiotensin-converting enzyme alleles were identified using primers to bracket the insertion region in intron 16. Amplification using polymerase chain reaction allowed identification of a 490-bp (I allele) or a 190-bp (D allele) product, or both. RESULTS Allelic and genotypic frequencies in control subjects were similar to those reported in mostly male populations, and frequencies of genotypes were in the Hardy-Weinberg equilibrium. In contrast, the distribution of genotypes in patients with MI diverged from the equilibrium. Specifically, DD genotypic frequency was increased in women with (n = 141) versus without (n = 338) a previous MI (39% vs. 29%, odds ratio [OR] 1.54, 95% confidence interval 1.02 to 2.32, p < 0.04). Risk was particularly increased in women <60 years old (OR 2.04, p < 0.05). In contrast, the DD genotype did not predict angiographic coronary artery disease. CONCLUSIONS Consistent with findings in male-dominated populations, a modest association of the ACE DD genotype with MI was found in women. The basis for this association requires further study.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
March 1995, Circulation,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
August 1995, Cardiology clinics,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
August 2004, Medical science monitor : international medical journal of experimental and clinical research,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
October 1999, The American journal of cardiology,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
January 1994, Indian heart journal,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
July 2019, Journal of cardiovascular pharmacology and therapeutics,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
January 2005, Annals of internal medicine,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
January 2005, Annals of internal medicine,
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
September 1995, BMJ (Clinical research ed.),
J L Anderson, and J F Carlquist, and G J King, and L Morrison, and M J Thomson, and E H Ludwig, and J B Muhlestein, and T L Bair, and R H Ward
September 1994, Lancet (London, England),
Copied contents to your clipboard!